In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: CME Group’s current price at $266.17 is 40.8% below the high-confidence fair value of $374.88, indicating undervaluation supported by multiple valuation methods. Strong liquidity and profitability contrast with low growth and efficiency scores, suggesting operational challenges amid solid financial health. Monte Carlo analysis reveals high upside potential but significant volatility and a 33.3% downside risk below current levels.